MS

Mohammad Sadre Alam

Active Director Director DIN 10525591
DIN 10525591 First appointment Feb 2024 Primary industry Paper
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Mohammad Sadre Alam

Data last updated:

Mohammad Sadre Alam is a Director at Cureyug Pharmaceuticals Private Limited (since 2024). The company operates in Paper.

DIN 10525591
Primary Designation Director
Industry Paper
First Appointment 27 Feb 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director27 Feb 20242024Active

Board colleagues of Mohammad Sadre Alam

NameDINCompanyDesignation
Tarana Jahan10525590Cureyug Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Cureyug Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Mohammad Sadre Alam

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Mohammad Sadre Alam

Mohammad Sadre Alam currently holds 1 directorship: Cureyug Pharmaceuticals Private Limited (Director, since 27 Feb 2024).

Mohammad Sadre Alam was first appointed on 27 Feb 2024 as Director at Cureyug Pharmaceuticals Private Limited.

The current boards of Mohammad Sadre Alam's companies include Tarana Jahan (Cureyug Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available